OHR PHARMACEUTICAL INC's ticker is OHRP and the CUSIP is 67778H200. A total of 6 filers reported holding OHR PHARMACEUTICAL INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $45,000 | +650.0% | 70,933 | +805.9% | 0.01% | +400.0% |
| Q1 2017 | $6,000 | +20.0% | 7,830 | +130.0% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | +400.0% | 3,405 | +600.6% | 0.00% | – |
| Q2 2016 | $1,000 | -75.0% | 486 | -65.3% | 0.00% | -100.0% |
| Q1 2016 | $4,000 | -42.9% | 1,400 | +24.3% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | -30.0% | 1,126 | -72.2% | 0.00% | 0.0% |
| Q2 2015 | $10,000 | +42.9% | 4,052 | +414.9% | 0.00% | 0.0% |
| Q4 2014 | $7,000 | -87.7% | 787 | -90.1% | 0.00% | -83.3% |
| Q3 2014 | $57,000 | +147.8% | 7,926 | +227.0% | 0.01% | +100.0% |
| Q2 2014 | $23,000 | +475.0% | 2,424 | +811.3% | 0.00% | +200.0% |
| Q1 2014 | $4,000 | -83.3% | 266 | -91.4% | 0.00% | -75.0% |
| Q4 2013 | $24,000 | +242.9% | 3,078 | +242.0% | 0.00% | +300.0% |
| Q3 2013 | $7,000 | +75.0% | 900 | +99.1% | 0.00% | – |
| Q2 2013 | $4,000 | – | 452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 409,200 | $76,000 | 0.06% |
| Leisure Capital Management | 63,360 | $12,000 | 0.01% |
| Bryn Mawr Capital Management, LLC | 14,200 | $3,000 | 0.00% |
| Virtu Financial LLC | 189,095 | $35,000 | 0.00% |
| WEDBUSH SECURITIES INC | 75,000 | $14,000 | 0.00% |
| MORGAN STANLEY | 5,650 | $1,000 | 0.00% |
| BRYN MAWR TRUST Co | 10,000 | $2,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 78,800 | $15,000 | 0.00% |
| BlackRock Inc. | 413,137 | $77,000 | 0.00% |
| Bank of New York Mellon Corp | 34,472 | $6,000 | 0.00% |